Lululemon Athletica

LULU · NASDAQ

$99.94+$2.18 (+2.23%)TodayMarket closed · Oct 20, 7:58 PM ET

Prev close $97.76

LULU analyst rating

HoldConsensus of 25 analysts over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold21
Underperform3
Sell1

12-month price target · 30 analysts

Average $109.03 (+9.1% upside)

Low: $70.70
Now: $99.94
High: $265.23

Upgrades and downgrades

The latest rating actions, newest first

LULU analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Wells Fargo	Oct 19, 2026	Maintains	Equal-Weight	$95.00 → $90.00	54%
Argus Research	Sep 14, 2026	Maintains	Hold	—	75%
Citigroup	Sep 9, 2026	Maintains	Neutral	$130.00 → $117.00	53%
BMO Capital	Sep 9, 2026	Initiates	Underperform	$70.00	74%
Telsey Advisory Group	Sep 4, 2026	Maintains	Market Perform	$122.00 → $110.00	47%
Barclays	Sep 4, 2026	Maintains	Equal-Weight	$113.00 → $95.00	55%
BNP Paribas	Sep 4, 2026	Maintains	Underperform	$88.00 → $44.00	48%
Goldman Sachs	Sep 4, 2026	Maintains	Neutral	$111.00 → $95.00	53%
Piper Sandler	Sep 4, 2026	Maintains	Neutral	$110.00 → $80.00	49%
Stifel	Sep 4, 2026	Maintains	Hold	$134.00 → $100.00	30%

The case for and against

Updated Oct 21, 2026

Bull case

Lululemon Athletica is viewed positively because 2Q results showed resilient profitability despite softer demand, with revenue of $2.416 billion and EPS of $2.06 beating depressed Street expectations. Even with Americas comps down 12% CC and China sales of $407 million, the company delivered a 54.9% gross margin excluding tariff refunds and 13.2% operating margin, signaling strong underlying earnings power. The outlook also remains constructive because new products are resonating with consumers, and any quicker product improvement could accelerate top-line growth and support further share appreciation.

Bear case

Lululemon Athletica is facing a deteriorating fundamental setup as soft consumer response to new launches, negative brand sentiment, and intensifying challenger-brand competition are pressuring traffic and full-price sell-through across regions. Management’s FY26 outlook was cut materially to $10.35 billion-$10.5 billion of revenue and $9.48-$9.73 of EPS, with 3Q revenue guided to $2.29 billion-$2.32 billion and EPS of $0.93-$0.98, signaling broad-based demand weakness and markdown pressure. With limited visibility into when earnings may bottom, a leadership transition, and margin headwinds from promotions, tariffs, and expense deleverage, the stock’s risk appears skewed to the downside.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.